ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,800,000 | +65.1% | 705,608 | +100.0% | 0.15% | -12.1% |
| Q3 2021 | $11,992,000 | -58.4% | 352,804 | -50.0% | 0.17% | -7.0% |
| Q2 2021 | $28,832,000 | +103.0% | 705,608 | +100.0% | 0.19% | +3.9% |
| Q1 2021 | $14,204,000 | -73.5% | 352,804 | -61.0% | 0.18% | -68.6% |
| Q4 2020 | $53,504,000 | +32.6% | 904,854 | +9.0% | 0.57% | -2.5% |
| Q3 2020 | $40,363,000 | +73.8% | 830,000 | +72.9% | 0.59% | +56.6% |
| Q2 2020 | $23,222,000 | +73.0% | 480,000 | -3.0% | 0.38% | +7.4% |
| Q1 2020 | $13,424,000 | +47.1% | 495,000 | +62.3% | 0.35% | +93.4% |
| Q4 2019 | $9,126,000 | +0.1% | 305,000 | +3.4% | 0.18% | -26.4% |
| Q3 2019 | $9,116,000 | -33.8% | 295,000 | +3.5% | 0.25% | -22.2% |
| Q2 2019 | $13,766,000 | – | 285,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |